Biogaia investor relations
Web2024. When we started BioGaia more than 30 years ago, our motto was ‘do good and have fun’. With this attitude as our guiding light we have developed into a world-leading … WebBioGaia contributes to better health by selling products with clinically-proven effects. Our business's health is not only determined by how our products affect our consumers directly but also by their impact on the …
Biogaia investor relations
Did you know?
WebFeb 14, 2024 · Investor Relations Dept Catalent, Inc. 14 Schoolhouse Road Somerset, NJ 08873 Phone: +1 732 537 6325 Fax: +1 732 537 5932 Mail: [email protected]. Quick Links. SEC Filings; Investor FAQs; Information Request Form; Investor Email Alerts. WebBioGaia AB develops and markets a wide range of probiotic products with documented health benefits. The company is focused on human health, animal health and the …
WebFeb 28, 2024 · Investor Relations. Joseph Suarez Vice President, Investor Relations T: 773-551-4397 [email protected]. David Paccapaniccia Analyst, Senior Investor Relations T: 585-282-7227 [email protected]. Snehal Shah Director, Investor Relations T: 847-385-4940 [email protected] WebNov 2, 2024 · In addition to BioGaia, EQT Public Value has previously disclosed positions in Securitas, BHG Group AB, Storebrand, Adapteo and AFRY AB. Contact. Niklas Ringby, Co-Head and Investment Advisor to EQT Public Value and Partner at EQT Partners, +46 8 506 55 398. EQT Press Office, [email protected], +46 8 506 55 334. About EQT.
WebApr 3, 2024 · Alimak Group’s interim report for January–March 2024 will be published on 3 May, at 08:00 CEST. A teleconference for investors, analysts and financial media will be held at 10.00 CEST on Wednesday 3 May. CEO Ole Kristian Jødahl and CFO Sylvain Grange will present and comment on the report. The presentation, held in English, can … WebDec 31, 2024 · On 1 January 2012, the shares were moved from the Small Cap List to the Mid Cap List. In 2024, an average of 28,852 shares were trading each day for an average of SEK 13,208,910 per day. The number of shareholders at 31 December 2024 was 8,709 (9,064). The total registered share capital of BioGaia AB consists of 3,703,340 class A …
WebPresentation Q1 2024. This cookie is used to be able to launch new site functionality to a smaller part of the visitors. This cookie is used to detect and defend when a client …
WebBioGaia investor relations material. Listen to the latest call from BioGaia. Companies 8; BioGaia; BioGaia AB develops and markets a wide range of probiotic products with documented health benefits. The company is focused on human health, animal health and the environment, and creates new benefits through the development of novel target … granit wolbromWebMay 4, 2024 · Investor Relations; ESG Reporting Guide; European Markets; Nasdaq Nordic Foundation; Nasdaq Thought Leadership; Nasdaq Initiatives The Purpose … chinook hobby shop calgaryWebApr 5, 2024 · Presentation. Audiocast. Other. Year-end Report 2024-02-09. Erik Penser Banks Temadag HealthCare 2024-12-01. SEB Healthcare Seminar 2024 2024-11-21. Interim Report Q3 2024-10-27. Interim Report Q2 2024-07 … granit wohnaccessoiresWebApr 7, 2024 · Investor Relations BioGaia AB Class B BIOG B Stock Quote Morningstar Rating ... BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has ... chinook hobby westWebNov 2, 2024 · BioGaia is listed in the Mid Cap segment on Nasdaq Stockholm and reported net sales of SEK 768 million and EBIT of SEK 243 million in 2024. The Company has a … granitworldWebSartorius Stedim Biotech Group FY 2024 Results. / 24. Sales revenue of 3,493 million euros, in constant currencies up 13.2 percent organically and up 15.1 percent including acquisitions (reported: up 21.0 percent) Underlying EBITDA at 1,221 million euros, resulting margin at 35.0 percent. As expected noticeable normalization of demand. granit wolfrum nailaWebNov 3, 2024 · Swedish private equity firm EQT AB (publ), through its EQT Public Value fund, aims to purchase 1,625,000 B shares of BioGaia AB (publ) in the probiotic food supplement company's directed issue, representing a consideration of 650 million Swedish kronor. The proposed share issuance is subject to approval at BioGaia's extraordinary general meeting. granit wiscont white